Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D2V6BI
|
|||
| Drug Name |
AV-1 mAb
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Dengue [ICD-11: 1D20-1D2Z; ICD-10: A90, R50] | Phase 1 | [1] | |
| Company |
AbViro
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04273217) A Study to Determine the Safety of AV-1, an Antibody Being Developed for Treatment of Dengue, in Healthy Volunteers. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.